Dr. Atlas on the Current Treatment Paradigm in CSCC

Jennifer L. Atlas, MD, a medical oncologist specializing in lung cancer at Levine Cancer Institute, Carolinas HealthCare System/Atrium Health, discusses the ​current cutaneous squamous cell carcinoma (CSCC)​ treatment paradigm.

The standard of care for patients with local​ly advanced CSCC is surgical resection, says Atlas.

The majority of patients with low-risk CSCC will undergo surgical resection, Atlas explains. However, whether systemic therapies provide additional benefit to surgical resection is not well defined.

However, in situations where the disease cannot be ​fully resected or ​the patient is considered to be at high risk for surgery, systemic therapies such as cemiplimab​-rwlc ​(Libtayo) ​should be considered, Atlas concludes.